
Last month, Pfizer and BioNTech announced that their two-dose vaccine had an efficacy rate of 95% after two doses administered three weeks apart. The new analyses show that the protection starts kicking in far earlier.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/33T1dkE
via
IFTTT
0 comments:
Post a Comment